News and Announcements
Analytica’s AutoStart Burette Granted US Patent
- Published July 15, 2016 11:30AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
15th July 2016, ASX Announcement
Analytica (ASX:ALT) is pleased to announce that the AutoStart® burette system has been granted patent protection by the US Patent and Trademarks Office.
US Patent 9352080 has a priority date of 13 October 2005 and will expire on 17 Jan 2031, provided all renewal fees are paid.
CEO Geoff Daly said “Obtaining patent protection in the world’s largest medical device market is a major milestone and an important step in the commercialisation of the AutoStart infusion System. The patent process is lengthy and complex, with this national phase patent taking more than 10 years from the priority date. This patent is one of a number of AutoStart burette patents being pursued in the major medical device markets.”
To view the full announcement, please click on the button below.